See more : The Chugoku Electric Power Co., Inc. (9504.T) Income Statement Analysis – Financial Results
Complete financial analysis of Taihe Group, Inc. (TIHE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Taihe Group, Inc., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Fosun International Limited (0656.HK) Income Statement Analysis – Financial Results
- Absa Group Limited (AGRPY) Income Statement Analysis – Financial Results
- Healthcare Trust, Inc. (HTIA) Income Statement Analysis – Financial Results
- IndiaMART InterMESH Limited (INDIAMART.BO) Income Statement Analysis – Financial Results
- Sinolink Securities Co., Ltd. (600109.SS) Income Statement Analysis – Financial Results
Taihe Group, Inc. (TIHE)
Industry: Medical - Diagnostics & Research
Sector: Healthcare
About Taihe Group, Inc.
Taihe Group, Inc. does not have significant operations. Previously, it was operated as commercial laboratory and provided predictive chemosensitivity and immunotherapy predictive tests on biopsy tissues and other oncological laboratory testing services and products. The company was formerly known as NuOncology Labs, Inc. and changed its name to Taihe Group, Inc. in April 2022. Taihe Group, Inc. was incorporated in 1994 and is based in Scottsdale, Arizona.
| Metric | 2022 | 2021 | 2020 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 43.97K | 29.22K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 43.97K | 29.22K | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 43.97K | 29.22K | 0.00 |
| Cost & Expenses | 43.97K | 29.22K | 0.00 |
| Interest Income | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 0.00 | 236.56K | 206.30K |
| EBITDA | -43.97K | -29.22K | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% |
| Operating Income | -43.97K | -29.22K | 0.00 |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -43.97K | -29.22K | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -29.22 | 0.00 |
| Net Income | -43.97K | -29.22K | 0.00 |
| Net Income Ratio | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | -7.48 | 0.00 |
| EPS Diluted | 0.00 | -7.48 | 0.00 |
| Weighted Avg Shares Out | 62.81M | 3.91K | 3.24K |
| Weighted Avg Shares Out (Dil) | 62.74M | 3.91K | 3.24K |
Source: https://incomestatements.info
Category: Stock Reports